Skip to content

ASSERTIO THERAPEUTICS, INC.: filings

Every ASSERTIO THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 37 filings, each linked to its SEC index.

Filing record ends 2020-05-11

The latest filing in this captured record is a 10-Q filed 2020-05-11. No later filing is in the SEC companyfacts record captured on 2026-09-22. ASSERTIO THERAPEUTICS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2020-05-11fiscal Q1 202045940001005201-20-000035
10-K2020-03-10fiscal FY 2019571850001005201-20-000021
10-Q2019-11-07fiscal Q3 2019541520001005201-19-000121
10-Q2019-08-09fiscal Q2 2019501380001005201-19-000093
10-Q2019-05-09fiscal Q1 2019501030001005201-19-000072
10-K2019-03-11fiscal FY 2018531840001005201-19-000040
10-Q2018-11-09fiscal Q3 2018471280001005201-18-000014
10-Q2018-08-08fiscal Q2 2018471270001558370-18-006734
10-Q2018-05-10fiscal Q1 201846920001558370-18-004605
10-K2018-03-01fiscal FY 2017511730001558370-18-001325
10-Q2017-11-09fiscal Q3 2017421070001558370-17-008609
10-Q2017-08-07fiscal Q2 2017411050001558370-17-006114
10-Q2017-05-10fiscal Q1 201736730001558370-17-004059
10-K2017-02-24fiscal FY 2016481710001558370-17-000959
10-Q2016-11-07fiscal Q3 201637980001558370-16-009561
10-Q2016-08-03fiscal Q2 201636960001558370-16-007238
10-Q2016-05-06fiscal Q1 201640810001104659-16-118682
10-K2016-02-26fiscal FY 2015481720001047469-16-010509
10-Q2015-11-09fiscal Q3 2015391080001104659-15-077307
10-Q2015-08-03fiscal Q2 2015381080001410578-15-000409
10-Q2015-05-11fiscal Q1 201537760001104659-15-036895
10-K2015-02-26fiscal FY 2014451650001047469-15-001308
10-Q2014-11-06fiscal Q3 2014381070001104659-14-077730
10-Q2014-08-06fiscal Q2 2014381070001104659-14-057635
10-Q2014-05-09fiscal Q1 201438770001104659-14-037081
10-K2014-03-17fiscal FY 2013441570001047469-14-002523
10-Q2013-11-07fiscal Q3 2013351000001104659-13-082368
10-Q2013-08-08fiscal Q2 2013351000001104659-13-061711
10-Q2013-05-09fiscal Q1 201336720001104659-13-039582
10-K2013-02-22fiscal FY 2012421560001047469-13-001503
10-Q2012-11-05fiscal Q3 201236990001104659-12-074227
10-Q/A2012-08-13fiscal Q2 201236970001104659-12-057399
10-Q2012-08-03fiscal Q2 201236970001104659-12-054154
10-Q2012-05-08fiscal Q1 201235720001104659-12-034523
10-K2012-03-08fiscal FY 2011371020001047469-12-002308
10-Q2011-11-07fiscal Q3 201134940001104659-11-061663
10-Q2011-08-02fiscal Q2 201134940001104659-11-042703

Inspect the source

Entity
ASSERTIO THERAPEUTICS, INC. / CIK 0001005201
Captured
SEC response SHA-256
a0888eafc2c00d329fd2fca43d32b6d38515cf5cd1a52473a76535f5ff6a9620

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001005201.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))